Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,683 | 0 | N/A | 0 | 0 |
| Receivables | 991 | 0 | N/A | 0 | 0 |
| Inventories | 770 | 0 | N/A | 0 | 0 |
| TOTAL | $23,842 | $0 | $N/A | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 3,025 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 292 | 0 | 0 | 0 | 0 |
| TOTAL | $3,317 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $27,159 | $0 | $N/A | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,906 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 5,387 | 0 | N/A | 0 | 0 |
| TOTAL | $9,793 | $0 | $N/A | $0 | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,826 | 0 | N/A | 0 | 0 |
| Deferred Revenues | 2,500 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 175 | 0 | 0 | 0 | 0 |
| TOTAL | $9,129 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $18,922 | $0 | $N/A | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,990 | N/A | N/A | N/A | N/A |
| Common Shares | 1 | 0 | N/A | 0 | 0 |
| Retained earnings | -73,455 | 0 | N/A | 0 | 0 |
| Other shareholders' equity | 79,025 | 0 | 0 | 0 | 0 |
| TOTAL | $8,237 | $0 | $N/A | $0 | $0 |
| Total Liabilities And Equity | $27,159 | $0 | $0 | $0 | $0 |